


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.09%
+3.09%
-5.52%
+2.06%
+1.86%
TGTX
TG Therapeutics
$30.57
Strengths

Earnings are forecast to grow
TGTX Price Performance
$30.98 (-1.32%)
$33.49 (-8.72%)
$28.28 (+8.10%)
$32.91 (-7.11%)
TGTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
TGTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TGTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
TGTX has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
TGTX
TG Therapeutics
30.57
-0.46%
ATER
Aterian
0.77
-0.14%
POWL
Powell Industries
419.98
+3.56%
ALG
Alamo Group
192.57
-0.07%
EPAC
Enerpac Tool Group
40.70
-1.81%
What is TGTX current stock price?
What are TGTX stock strengths?
What is TGTX Risk Level?
What is TGTX market cap and volume?
What is TGTX current Stock IQ?
Should I buy TGTX stock right now?
Is TGTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for TGTX?
What does a 'Strong Sell' rating mean for TGTX?
What factors influence TGTX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.09%
+3.09%
-5.52%
+2.06%
+1.86%
TGTX
TG Therapeutics
Current Price
$30.57
Stock Insights
Strengths

Earnings are forecast to grow
Recently Viewed
TGTX
TG Therapeutics
30.57
-0.46%
ATER
Aterian
0.77
-0.14%
POWL
Powell Industries
419.98
+3.56%
ALG
Alamo Group
192.57
-0.07%
EPAC
Enerpac Tool Group
40.70
-1.81%

TGTX Price Performance
$30.98 (-1.32%)
$33.49 (-8.72%)
$28.28 (+8.10%)
$32.91 (-7.11%)
TGTX Analysts Opinion
TGTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
TGTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TGTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
TGTX has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
TGTX Stock IQ
TGTX Latest Analysis
TG Therapeutics Stock Rises 7% on Strong Q4 & 2025 Preliminary Results. TGTX jumps after preliminary 2025 sales beat guidance. Its ish 2026 revenue target and multiple Briumvi pipeline milestones also draw attention.
Wed Jan 14, 2026
TG Therapeutics stock holds Overweight rating at Cantor Fitzgerald.
Wed Jan 14, 2026
TG Therapeutics Clover Health Investments Nutrien And Other Big Stocks Moving Higher On Wednesday. United States stocks were lower with the Nasdaq Composite falling more than 200 points on Wednesday.Shares of ) rose sharply during Wednesday'.s session after the company reported preliminary fiscal-year 2025 total global revenue results on Tuesday .TG Therapeutics said preliminary total global revenue for full-year 2025 was approximately $616 million. The company reported preliminary United St
Wed Jan 14, 2026
TG Therapeutics Inc. (TGTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Tue Jan 13, 2026
TG Therapeutics Stock Climbs After The Bell: Heres Why. ) shares climbed in Tuesday’.s extended trading after the company released its preliminary fourth quarter revenue estimates and provided an optimistic outlook for 2026. Here’.s a lTG Therapeutics said it expects ...
Tue Jan 13, 2026
Notable Tuesday Option Activity: TGTX SPOT TECH. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in TG Therapeutics Inc (Symbol: TGTX) where a total volume of 11855 contracts has been traded thus far today a contract volume which is representative of approxi
Tue Jan 13, 2026
TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference. Presentation scheduled for Tuesday January 13 2026 at 1:30 PM PST
Wed Jan 7, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TGTX Stock trends
TGTX Stock performance
TGTX Stock analysis
TGTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.